Search research articles
Contact Us
Filters
Showing results (161-170 of 269) with videos related to
Page
of 27
Sort By:
Archives of General Psychiatry
|
July 1, 1993
Effects of metabolic perturbation on plasma homovanillic acid in schizophrenia. Relationship to prefrontal cortex volume
A Breier, O R Davis, R W Buchanan, et al.
Schizophrenia Research
|
October 11, 1991
Psychopathology and the question of neurodevelopmental or neurodegenerative disorder
W T Carpenter, R W Buchanan, A Breier, et al.
The American Journal of Psychiatry
|
October 10, 1998
Dopamine D2 receptor density and personal detachment in healthy subjects
A Breier, L Kestler, C Adler, et al.
The American Journal of Psychiatry
|
June 1, 1995
Patient response and resource management: another view of clozapine treatment of schizophrenia
W T Carpenter, R R Conley, R W Buchanan, et al.
General Physiology and Biophysics
|
March 16, 2007
Structural differences between sensitive and resistant L1210 cells
B Uhrík, A H El-Saggan, M Seres, et al.
The Journal of Nervous and Mental Disease
|
November 5, 1997
Failure of fusion of the septum pellucidum and the heterogeneity of schizophrenia
B Kirkpatrick, D Litman, J W Kim, et al.
The American Journal of Psychiatry
|
January 1, 1986
Combination alprazolam-neuroleptic treatment of the positive and negative symptoms of schizophrenia
O M Wolkowitz, D Pickar, A R Doran, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 15, 2000
Measurement of dopamine release with continuous infusion of [11C]raclopride: optimization and signal-to-noise considerations
H Watabe, C J Endres, A Breier, et al.
Nature Communications
|
November 18, 2015
Genomic and transcriptomic evidence for scavenging of diverse organic compounds by widespread deep-sea archaea
Meng Li, Brett J Baker, Karthik Anantharaman, et al.
Life Sciences
|
October 19, 1987
Prednisone decreases CSF somatostatin in healthy humans: implications for neuropsychiatric illness
O M Wolkowitz, D R Rubinow, A Breier, et al.
Page
of 27
Search research articles
Search
Showing results (161-170 of 269) with videos related to
Sort By:
Page
of 27
Archives of General Psychiatry
|
July 1, 1993
Effects of metabolic perturbation on plasma homovanillic acid in schizophrenia. Relationship to prefrontal cortex volume
A Breier, O R Davis, R W Buchanan, et al.
Schizophrenia Research
|
October 11, 1991
Psychopathology and the question of neurodevelopmental or neurodegenerative disorder
W T Carpenter, R W Buchanan, A Breier, et al.
The American Journal of Psychiatry
|
October 10, 1998
Dopamine D2 receptor density and personal detachment in healthy subjects
A Breier, L Kestler, C Adler, et al.
The American Journal of Psychiatry
|
June 1, 1995
Patient response and resource management: another view of clozapine treatment of schizophrenia
W T Carpenter, R R Conley, R W Buchanan, et al.
General Physiology and Biophysics
|
March 16, 2007
Structural differences between sensitive and resistant L1210 cells
B Uhrík, A H El-Saggan, M Seres, et al.
The Journal of Nervous and Mental Disease
|
November 5, 1997
Failure of fusion of the septum pellucidum and the heterogeneity of schizophrenia
B Kirkpatrick, D Litman, J W Kim, et al.
The American Journal of Psychiatry
|
January 1, 1986
Combination alprazolam-neuroleptic treatment of the positive and negative symptoms of schizophrenia
O M Wolkowitz, D Pickar, A R Doran, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 15, 2000
Measurement of dopamine release with continuous infusion of [11C]raclopride: optimization and signal-to-noise considerations
H Watabe, C J Endres, A Breier, et al.
Nature Communications
|
November 18, 2015
Genomic and transcriptomic evidence for scavenging of diverse organic compounds by widespread deep-sea archaea
Meng Li, Brett J Baker, Karthik Anantharaman, et al.
Life Sciences
|
October 19, 1987
Prednisone decreases CSF somatostatin in healthy humans: implications for neuropsychiatric illness
O M Wolkowitz, D R Rubinow, A Breier, et al.
Page
of 27